New Partnership Forms to Develop Breakthrough Neuromodulation Device

WeHealth, an e-health department of Servier Group, said it is in a partnership with Pathmaker Neurosystems, a pioneering clinical-stage bioelectronic medicine company. The two companies revealed plans to develop and commercialize the first neuromodulation technology designed to treat muscle spasticity non-invasively. The new technology will be known as the MyoRegulator device. The new MyoRegulator PM-200 provides a non-invasive treatment option for patients suffering from muscle spasticity, a common condition found in many patients suffering from stroke, cerebral palsy, multiple sclerosis, spinal cord injury, and traumatic brain injury. The condition results in certain muscles continuously contracting, resulting in an interference with normal movement, speech, and gait. Nader Yaghoubi, president and CEO of Pathmaker, says that the new technology was one of the first devices selected under the Expedited Access Pathway (EAP) program from FDA, a program intended for breakthrough medical devices. “The device is based on Pathmaker’s proprietary DoubleStim technology, which provides non-invasive stimulation simultaneously at spinal and peripheral sites associated with the targeted muscle,” he says. “This results in suppression of hyperexcitable spinal circuits found in patients with spasticity. The device is intended to be administered by a medical professional in a clinical setting, and treatments last 20 minu...
Source: MDDI - Category: Medical Devices Authors: Tags: Business Source Type: news

Related Links:

Publication date: Available online 2 June 2020Source: The Journal of Foot and Ankle SurgeryAuthor(s): Sergio Agudiez Calvo, Jorge Ballesteros de Frutos, Héctor Raúl Cabezas García, Daniel Pecos Martin, Tomás Gallego Izquierdo
Source: The Journal of Foot and Ankle Surgery - Category: Orthopaedics Source Type: research
Source: BMJ - Category: General Medicine Source Type: research
Conclusions: In the largest study to date of symptomatic individuals under 50 years of age undergoing colonoscopy in the USA, advanced CRN was most often detected in the distal colon and was associated with anemia, but not with abnormal bowel habits or abdominal pain. We also found that patients with CRN under 50 years of age were more likely to be male, smokers, and obese. These findings should prompt further investigation of these risk factors alone and in combination.
Source: European Journal of Gastroenterology and Hepatology - Category: Gastroenterology Tags: Original Articles: Gastroenterology Source Type: research
Publication date: Available online 2 June 2020Source: Annals of Emergency MedicineAuthor(s): Nicole C. O’Connell, Hilary A. Woodward, Pamela L. Flores-Sanchez, Son H. McLaren, Maria Ieni, Kenneth W. McKinley, Sripriya T. Shen, Peter S. Dayan, Daniel S. Tsze
Source: Annals of Emergency Medicine - Category: Emergency Medicine Source Type: research
Publication date: Available online 3 June 2020Source: Pharmacological ResearchAuthor(s): Marco Carli, Sandra Donnini, Carolina Pellegrini, Erika Coppi, Guido Bocci
Source: Pharmacological Research - Category: Drugs & Pharmacology Source Type: research
Publication date: Available online 2 June 2020Source: Journal of EthnopharmacologyAuthor(s): Li-Mei Feng, Yan-Yan Chen, Ding-Qiao Xu, Rui-Jia Fu, Shi-Jun Yue, Qi Zhao, Yu-Xi Huang, Xue Bai, Mei Wang, Li-Ming Xing, Yu-Ping Tang, Jin-Ao Duan
Source: Journal of Ethnopharmacology - Category: Drugs & Pharmacology Source Type: research
Publication date: Available online 19 May 2020Source: BurnsAuthor(s): Narges Sadeghi, Azim Azizi, Shadi Asgari, Younes Mohammadi
Source: Burns - Category: Dermatology Source Type: research
(CNN) — Still taking a daily aspirin to ward off heart attacks? You might want to think again, according to a new review. Aspirin is still one of the most commonly used medications in the world, even though it’s no longer recommended as a preventative by many health authorities. There is no evidence that low-dose aspirin — less than 325 milligrams a day — should be taken by most adults in good cardiovascular health, according to a new review of existing research that published Wednesday in the British Journal of Clinical Pharmacology. The review, which focused on the risks and benefits of low-dose d...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Health News aspirin CNN Source Type: news
France's coronavirus death toll rose by 81 on Wednesday, or 0.3%, to reach 29,021, the fifth-highest death toll in the world, and the number of confirmed cases rose again after they went down Tuesday due to an adjustment in reporting.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
مقدمه:(AFP) Atypical Facial Pain به صورت احساس درد مخاط دهان بدون هیچگونه اختلال مخاطی قابل مشاهده، در حین معاینات کلینیکی مشخص می شود. پزشکانی که با درد آتیپیک صورت آشنا نیستند علائم بیماران را جدی نمی گیرند و این حس را یک حس غیر واقعی می دانند، این عدم توجه پزشکان نه تنها موجب افزایش اضطراب بیمار بلکه باعث افزایش حس درد بیماران نیز می شود. مو اد و روش ها: در ا...
Source: Journal of Mashhad Dental School - Category: Dentistry Source Type: research
More News: Anaphylactic Shock | Back Pain | Baclofen | Brain | Cerebral Palsy | Clinical Trials | France Health | Funding | Hospitals | Medical Devices | Multiple Sclerosis | National Institutes of Health (NIH) | Neurology | Pain | Partnerships | Pneumonia | Spinal Cord Injury | Stroke